Evidence map›Paper›PMID 40057743›Full record

ArticleRespiratory research2025

Prediction of tumor spread through air spaces with an automatic segmentation deep learning model in peripheral stage I lung adenocarcinoma.

Cong Liu, Yu-Feng Wang, Ping Gong, Xiu-Qing Xue, Hong-Ying Zhao, Hui Qian, Chao Jia, Xiao-Feng Li

Abstract read
In one paragraph

Article in Respiratory research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Cong LiuDepartment of Minimally Invasive Oncology, Xuzhou New Health Geriatric Hospital, Xuzhou, People's Republic of China.
Yu-Feng WangDepartments of Nuclear Medicine, The Xuzhou Hospital Affiliated to Jiangsu University, Xuzhou Cancer Hospital, Xuzhou, People's Republic of China.
Ping GongSchool of Medical Imaging, Xuzhou Medical University, Xuzhou, People's Republic of China. gongping@xzhmu.edu.cn.
Xiu-Qing XueDepartment of Nuclear Medicine, The First People's Hospital of Yancheng, Yancheng, People's Republic of China.
Hong-Ying ZhaoDepartment of Radiotherapy, The Xuzhou Hospital Affiliated to Jiangsu University, Xuzhou Cancer Hospital, Xuzhou, People's Republic of China.
Hui QianMedical College of Jiangsu University, Zhenjiang, People's Republic of China. 1stmmm1st@163.com.
Chao JiaDepartment of Radiology, The Xuzhou Hospital Affiliated to Jiangsu University, Xuzhou Cancer Hospital, Xuzhou, People's Republic of China.
Xiao-Feng LiDepartment of Radiology, The Xuzhou Hospital Affiliated to Jiangsu University, Xuzhou Cancer Hospital, Xuzhou, People's Republic of China. lxf5818@163.com.

Funding

Clinical medicine science and technology development foundation of Jiangsu University Pro. No. JLY2021082Key Project of Yancheng Municipal Health Commission YK2023007Natural Science Foundation of China No. 82001987Xuzhou Science and Technology Bureau Project KC23229
6 · The paper itself

Abstract

backgroundTo evaluate the clinical applicability of deep learning (DL) models based on automatic segmentation in preoperatively predicting tumor spread through air spaces (STAS) in peripheral stage I lung adenocarcinoma (LUAD).

methodsThis retrospective study analyzed data from patients who underwent surgical treatment for lung tumors from January 2022 to December 2023. An external validation set was introduced to assess the model's generalizability. The study utilized conventional radiomic features and DL models for comparison. ROI segmentation was performed using the VNet architecture, and DL models were developed with transfer learning and optimization techniques. We assessed the diagnostic accuracy of our models via calibration curves, decision curve analysis, and ROC curves.

resultsThe DL model based on automatic segmentation achieved an AUC of 0.880 (95% CI 0.780-0.979), outperforming the conventional radiomics model with an AUC of 0.833 (95% CI 0.707-0.960). The DL model demonstrated superior performance in both internal validation and external testing cohorts. Calibration curves, decision curve analysis, and ROC curves confirmed the enhanced diagnostic accuracy and clinical utility of the DL approach.

conclusionThe DL model based on automatic segmentation technology shows significant promise in preoperatively predicting STAS in peripheral stage I LUAD, surpassing traditional radiomics models in diagnostic accuracy and clinical applicability. Clinical trial number The clinical trial was registered on April 22, 2024, with the registration number researchregistry10213 ( www.researchregistry.com ).

Indexed as

Adenocarcinoma of LungDeep LearningLung NeoplasmsAgedFemaleHumansMaleMiddle AgedNeoplasm StagingPredictive Value of TestsRetrospective StudiesTomography, X-Ray ComputedDeep LearningLung AdenocarcinomaRadiomicsTumor Spread through Air Spaces

Identifiers

PMID40057743
PMCPMC11890504

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.